Cargando…
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment
PURPOSE: Initial findings in patients with cancer suggest a lower seroconversion to SARS-CoV-2 vaccination possibly related to myelo-immunosuppressive therapies. We conducted a prospective study to assess factors predicting poor seroconversion and adverse events following immunisation (AEFI) to the...
Autores principales: | Buttiron Webber, Tania, Provinciali, Nicoletta, Musso, Marco, Ugolini, Martina, Boitano, Monica, Clavarezza, Matteo, D'Amico, Mauro, Defferrari, Carlotta, Gozza, Alberto, Briata, Irene Maria, Magnani, Monica, Paciolla, Fortuna, Menghini, Nadia, Marcenaro, Emanuela, De Palma, Raffaele, Sacchi, Nicoletta, Innocenti, Leonello, Siri, Giacomo, D'Ecclesiis, Oriana, Cevasco, Isabella, Gandini, Sara, DeCensi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502731/ https://www.ncbi.nlm.nih.gov/pubmed/34742157 http://dx.doi.org/10.1016/j.ejca.2021.09.030 |
Ejemplares similares
-
Home Se-Cure: A Home Care Service for Cancer Patients during the COVID-19 Pandemic
por: Buttiron Webber, Tania, et al.
Publicado: (2021) -
Inflammatory and Metabolic Biomarker Assessment in a Randomized Presurgical Trial of Curcumin and Anthocyanin Supplements in Patients with Colorectal Adenomas
por: Macis, Debora, et al.
Publicado: (2023) -
Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the art
por: Provinciali, Nicoletta, et al.
Publicado: (2022) -
Taste and Smell Disorders in Cancer Treatment: Results from an Integrative Rapid Systematic Review
por: Buttiron Webber, Tania, et al.
Publicado: (2023) -
Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer
por: Campora, Sara, et al.
Publicado: (2016)